EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+8.83%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$405M
AUM Growth
+$405M
(+5.2%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
74.32%
Holding
24
New
4
Increased
1
Reduced
8
Closed
3
Top Buys
| 1 |
UnitedHealth
UNH
|
$19M |
| 2 |
BridgeBio Pharma
BBIO
|
$11.2M |
| 3 |
Guardant Health
GH
|
$11M |
| 4 |
Scholar Rock
SRRK
|
$9.54M |
| 5 |
argenx
ARGX
|
$1.34M |
Top Sells
| 1 |
Inspire Medical Systems
INSP
|
$12.9M |
| 2 |
Ascendis Pharma
ASND
|
$8.81M |
| 3 |
Exact Sciences
EXAS
|
$8.76M |
| 4 |
Natera
NTRA
|
$7.4M |
| 5 |
DexCom
DXCM
|
$7.25M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$28.8B
| $43.1M | 10.65% | 428,600 -14,700 | -3% | -$1.48M |
|
|
2
argenx
ARGX
$43.6B
| $42.7M | 10.53% | 77,430 +2,440 | +3% | +$1.34M |
|
|
3
Natera
NTRA
$23.1B
| $39.9M | 9.84% | 235,964 -43,800 | -16% | -$7.4M |
|
4
Illumina
ILMN
$15.8B
| $32.8M | 8.09% | 343,361 | – | – |
|
5
Icon
ICLR
$13.8B
| $29.5M | 7.28% | 202,790 -6,400 | -3% | -$931K |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $27.3M | 6.74% | 217,200 -7,900 | -4% | -$993K |
|
|
7
DexCom
DXCM
$29.5B
| $23.9M | 5.9% | 273,821 -83,100 | -23% | -$7.25M |
|
8
Ultragenyx Pharmaceutical
RARE
$2.89B
| $22.8M | 5.63% | 627,600 | – | – |
|
9
BioMarin Pharmaceuticals
BMRN
$11.2B
| $20.2M | 4.98% | 366,812 -15,800 | -4% | -$869K |
|
|
10
UnitedHealth
UNH
$281B
| $19M | 4.69% | +60,888 | New | +$19M |
|
11
Procept Biorobotics
PRCT
$2.23B
| $17.2M | 4.25% | 299,089 | – | – |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $15M | 3.71% | 46,086 -19,570 | -30% | -$6.38M |
|
13
Akero Therapeutics
AKRO
$3.74B
| $12.1M | 2.98% | 226,400 | – | – |
|
|
14
Exact Sciences
EXAS
$8.98B
| $11.9M | 2.93% | 223,750 -164,900 | -42% | -$8.76M |
|
|
15
BridgeBio Pharma
BBIO
$9.89B
| $11.2M | 2.76% | +259,300 | New | +$11.2M |
|
|
16
Guardant Health
GH
$8.41B
| $11M | 2.72% | +212,000 | New | +$11M |
|
17
Agios Pharmaceuticals
AGIO
$2.19B
| $11M | 2.72% | 330,830 | – | – |
|
|
18
Scholar Rock
SRRK
$3.14B
| $9.54M | 2.36% | +269,400 | New | +$9.54M |
|
19
Intuitive Surgical
ISRG
$170B
| $2.39M | 0.59% | 4,390 | – | – |
|
20
Immunocore
IMCR
$1.62B
| $1.45M | 0.36% | 46,300 | – | – |
|
21
Vir Biotechnology
VIR
$686M
| $1.21M | 0.3% | 240,500 | – | – |
|
|
22
Ascendis Pharma
ASND
$11.8B
| – | – | -56,500 | Closed | -$8.81M |
|
|
23
Inspire Medical Systems
INSP
$2.77B
| – | – | -81,121 | Closed | -$12.9M |
|
24
Transmedics
TMDX
$3.92B
| – | – | -100,661 | Closed | -$6.77M |
|